Skip to main content

Table 3 Comparisons of satisfaction score of the current ART between the complete and incomplete ART adherence groups

From: Factors associated with incomplete adherence to integrase strand transfer inhibitor-containing single-tablet regimen among Japanese people living with HIV

Item labela

ART adherence

Satisfaction scoreb / Number (%)c

Median (IQR)

p valued

0

1

2

3

4

5

6

  

Size

Complete (n = 252)

4 (1.6)

2 (0.8)

9 (3.6)

25 (9.9)

45 (17.9)

60 (23.8)

107 (42.5)

5 (4–6)

0.043

Incomplete (n = 131)

5 (3.8)

1 (0.8)

6 (4.6)

21 (16.0)

27 (20.6)

23 (17.6)

48 (36.6)

5 (3–6)

 

Feeling while using

Complete (n = 252)

2 (0.8)

2 (0.8)

6 (2.4)

18 (7.1)

45 (17.9)

70 (27.8)

109 (43.3)

5 (4–6)

0.002

Incomplete (n = 131)

0 (0)

5 (3.8)

6 (4.6)

19 (14.5)

26 (19.8)

34 (26.0)

41 (31.3)

5 (4–6)

 

Color

Complete (n = 251)

6 (2.4)

2 (0.8)

3 (1.2)

25 (10.0)

27 (10.8)

59 (23.5)

129 (51.4)

6 (4–6)

0.052

Incomplete (n = 130)

3 (2.3)

1 (0.8)

3 (2.3)

20 (15.4)

13 (10.0)

37 (28.5)

53 (40.8)

5 (4–6)

 

Taste

Complete (n = 251)

1 (0.4)

0 (0)

1 (0.4)

28 (11.2)

21 (8.4)

55 (21.9)

145 (57.8)

6 (5–6)

0.012

Incomplete (n = 131)

2 (1.5)

1 (0.8)

6 (4.6)

17 (13.0)

14 (10.7)

30 (22.9)

61 (46.6)

5 (4–6)

 

Portability

Complete (n = 252)

3 (1.2)

7 (2.8)

8 (3.2)

21 (8.3)

40 (15.9)

55 (21.8)

118 (46.8)

5 (4–6)

0.004

Incomplete (n = 131)

4 (3.1)

6 (4.6)

8 (6.1)

15 (11.5)

24 (18.3)

30 (22.9)

44 (33.6)

5 (3–6)

 

Daily oral therapy

Complete (n = 253)

4 (1.6)

5 (2.0)

7 (2.8)

41 (16.2)

44 (17.4)

56 (22.1)

96 (37.9)

5 (4–6)

 < 0.001

Incomplete (n = 131)

7 (5.3)

8 (6.1)

15 (11.5)

21 (16.0)

30 (22.9)

27 (20.6)

23 (17.6)

4 (3–5)

 

Co-payment

Complete (n = 253)

1 (0.4)

3 (1.2)

6 (2.4)

29 (11.5)

22 (8.7)

52 (20.6)

140 (55.3)

6 (5–6)

0.810

Incomplete (n = 131)

1 (0.8)

3 (2.3)

8 (6.1)

15 (11.5)

9 (6.9)

20 (15.3)

75 (57.3)

6 (4–6)

 
  1. ART Anti-retroviral therapy
  2. aMissing data/nonresponses were excluded for the following items: size (n = 4), feeling while using (n = 4), color (n = 6), taste (n = 5), portability (n = 4), daily oral therapy (n = 3), and co-payment (n = 3)
  3. bEach item is rated on a Likert scale ranging from 0 (very dissatisfied) to 6 (very satisfied), with higher scores indicating greater satisfaction
  4. cThe sum may not equal 100% due to rounding to the second decimal place for each item in the table
  5. dMann–Whitney U test